News
Mylan and Pfizer’s Upjohnto combine and create a new biosimilar business
The new company will transform and accelerate each businesses’ ability to serve patients’ needs and expand their capabilities across more than 165 markets by bringing together 2 two highly complementary businesses.
DBT seeks comments/suggestions on Draft National Guidelines for Gene Therapy product development,clinical trials
The draft document is being placed in public domain for comments/suggestions from the concerned stakeholders (scientists, academics, industries working in the field).
Health Ministry develops National Strategic Plan with a goal to end TB by 2025
The Minister of State for Health and Family Welfare, Ashwini Kumar Choubey has stated in a written reply in the Lok Sabha recently about the status of tuberculosis in India and a revised action plan to contain TB.
Alvotech and Cipla Gulf partner to commercialize key biosimilar products in select markets
Under the partnership, Alvotech will be responsible for development and supply of the product, while Cipla Gulf will be responsible for registration and commercialization.
ICMR launches National Data Quality Forum: A platform to boost health data quality in India
The National Data Quality Forum (NDQF) hopes to bring together relevant stakeholders, subject matter experts, industry leaders, decision makers, and data scientists and analysts on a common platform to improve the quality of data
voice for BT and BEST 2026
